Clincosm LogoSign in Get a demo

Mobile Health Technology for Palliative Care Patients

Sponsor
University of Zurich (Other)
Overall Status
Unknown status
CT.gov ID
NCT03038841
Collaborator
Swiss Federal Institute of Technology (Other), Swiss Academy of Medical Sciences (SAMS) (Other)
30
Enrollment
1
Location
15.9
Anticipated Duration (Months)
1.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To test the potential and acceptance of wireless activity tracking in palliative care patients leaving hospital care. Explorative study, collaboration project of the Clinic of Radiation-Oncology, University Hospital Zurich and the Wearable Computing Laboratory, Swiss Federal Institut of Technology. Patients receive a tracking bracelet and a smart phone in order to gather objective physical activity parameters as step count, sleep duration, heart rate, social activity patterns (e.g. making calls) as well as subjective ratings of pain and distress. Quality of life (QoL) will be captured by paper questionnaire. Correlations between patients' physical activity patterns and the pain and distress level assessed from electronic scales as well as QoL-questionnaire will be performed. Acceptance will be evaluated by quantitative questionnaires and interviews. The proposed study is meant to be preparatory work for an intervention study to test the effect of wireless monitoring of palliative care patients on fostering early interventions for symptom relief and support of QoL.

Condition or Disease Intervention/Treatment Phase
  • Device: Mobile Health

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
30 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Mobile Health Technologies for Palliative Care Patients at the Interface of In-patient to Out-patient Care: A Feasibility Study Aiming to Early Predict Deterioration of Patient's Health Status
Actual Study Start Date :
Feb 1, 2017
Anticipated Primary Completion Date :
May 31, 2018
Anticipated Study Completion Date :
May 31, 2018

Outcome Measures

Primary Outcome Measures

  1. Feasibility (time of complete data transfer in weeks) [12 weeks]

    time of complete data transfer in weeks

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 105 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • established diagnosis of metastatic cancer or other severe illness with limited life-expectancy (physicians guess <12 months, > 8 weeks)

  • Karnofsky Index ≥50%

  • ECOG≤ 2

  • aged > 18 years

  • passed a short handling test with devices (tracking bracelet, smart phone)

Exclusion Criteria:

  • relevant cognitive impairment

  • insufficient knowledge of German language.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinic of Radiation-Oncology University Hospital Zurich Zürich Zurich Switzerland 8091

Sponsors and Collaborators

  • University of Zurich
  • Swiss Federal Institute of Technology
  • Swiss Academy of Medical Sciences (SAMS)

Investigators

  • Study Chair: Matthias Guckenberger, Prof, Clinic of Radiation-Oncology USZ
  • Study Chair: Gerhard Tröster, Prof, ETH Zürich
  • Principal Investigator: Gudrun Theile, MD, Clinic of Radiation-Oncology USZ

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Zurich
ClinicalTrials.gov Identifier:
NCT03038841
Other Study ID Numbers:
  • PC 16/16
First Posted:
Feb 1, 2017
Last Update Posted:
Jun 21, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Chronic Disease

Study Results

No Results Posted as of Jun 21, 2017